Journals / Diagnostic and Interventional Radiology / 2015 / Cilt: 21 - Sayı: 2

Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI

Pages
96–104
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Other parameters were not significantly different between the two types of nodules.CONCLUSIONThe absence of fat and fibrous capsule, and presence of en-hancement at three minutes appear to be most characteristic for mICC and may help its differentiation from pHCC

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSEWe aimed to gain further insight in magnetic resonance im-aging characteristics of mass-forming intrahepatic cholangio-carcinoma (mICC), its enhancement pattern with gadoxetic acid contrast agent, and distinction from poorly differentiat-ed hepatocellular carcinoma (pHCC).METHODSFourteen mICC and 22 pHCC nodules were included in this study.
📊
Key Findings & Data:Two observers recorded the tumor shape, intratumoral hemorrhage, fat on chemical shift imaging, signal intensity at the center of the tumor on T2-weighted image, fibrous capsule, enhancement pattern on arterial phase of dynamic study, late enhancement three minutes after contrast injec-tion (dynamic late phase), contrast uptake on hepatobiliary phase, apparent diffusion coefficient, vascular invasion, and intrahepatic metastasis.
💡
Conclusion & Impact:Other parameters were not significantly different between the two types of nodules.CONCLUSIONThe absence of fat and fibrous capsule, and presence of en-hancement at three minutes appear to be most characteristic for mICC and may help its differentiation from pHCC
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

PURPOSEWe aimed to gain further insight in magnetic resonance im-aging characteristics of mass-forming intrahepatic cholangio-carcinoma (mICC), its enhancement pattern with gadoxetic acid contrast agent, and distinction from poorly differentiat-ed hepatocellular carcinoma (pHCC).METHODSFourteen mICC and 22 pHCC nodules were included in this study. Two observers recorded the tumor shape, intratumoral hemorrhage, fat on chemical shift imaging, signal intensity at the center of the tumor on T2-weighted image, fibrous capsule, enhancement pattern on arterial phase of dynamic study, late enhancement three minutes after contrast injec-tion (dynamic late phase), contrast uptake on hepatobiliary phase, apparent diffusion coefficient, vascular invasion, and intrahepatic metastasis. RESULTSLate enhancement was more common in mICC (n=10, 71%) than in pHCC (n=3, 14%) (P < 0.001). A fat component was observed in 11 pHCC cases (50%) versus none of mICC cases (P = 0.002). Fibrous capsule was observed in 13 pHCC cases (59%) versus none of mICC cases (P < 0.001). On T2-weight-ed images a hypointense area was seen at the center of the tumor in 43% of mICC (6/14) and 9% of pHCC (2/22) cases (P = 0.018). Other parameters were not significantly different between the two types of nodules.CONCLUSIONThe absence of fat and fibrous capsule, and presence of en-hancement at three minutes appear to be most characteristic for mICC and may help its differentiation from pHCC

🔖

Cite This Article

ASAYAMA, Y., NİSHE, A., İSHİGAMİ, K., USHİJİMA, Y., TAKAYAMA, Y., FUJİTA, N., KUBO, Y., KUBO, Y., SHİRABE, K., YOSHİURA, T., HONDA, H. (2015). Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI. Diagnostic and Interventional Radiology, Cilt: 21 - Sayı: 2, 96–104. https://ajindex.com/articles/213056

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. The Liver Cancer Study Group of Ja- pan. The general rules for the clinical and pathological study of primary liver cancer. 5th ed. Tokyo: Kanehara, 2008. Lim JH. Cholangiocarcinoma: morpho- logic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 2003
  2. [CrossRef] Asayama Y, Yoshimitsu K, Irie H, et al. Delayed-phase dynamic CT en- hancement as a prognostic factor for mass-forming intrahepatic cholangio- carcinoma. Radiology 2006
  3. [CrossRef] Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangio- carcinoma with pathologic correlation. AJR Am J Roentgenol 2001
  4. [CrossRef] Lacomis JM, Baron RL, Oliver JH 3rd, Nalesnik MA, Federle MP. Cholangio- carcinoma: delayed CT contrast en- hancement patterns. Radiology 1997
  5. :98-104. [CrossRef] Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorpho- logic study on the mechanism of fatty change in small hepatocellular carcino- ma of humans. J Hepatol 2000
  6. [CrossRef] Asayama Y, Yoshimitsu K, Nishihara Y, et al. Arterial blood supply of hepato- cellular carcinoma and histologic grad- ing: radiologic-pathologic correlation. AJR Am J Roentgenol 2008
  7. W28- [CrossRef] Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respira- tory triggered diffusion-weighted sin- gle-shot echo-planar MR imaging tech- nique. Eur Radiol 2008
  8. CrossRef] Ringe KI, Husarik DB, Sirlin CB, Merkle EM. Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol opti- mization and lesion appearance in the noncirrhotic liver. AJR Am J Roentge- nol 2010
  9. [CrossRef] Asayama Y, Tajima T, Nishie A, et al. Uptake of Gd-EOB-DTPA by hepato- cellular carcinoma: radiologic-patho- logic correlation with special reference to bile production. Eur J Radiol 2011
  10. :e243-248. [CrossRef] Ishigami K, Yoshimitsu K, Nishihara Y, et al. Hepatocellular carcinoma with a pseudocapsule on gadolinium-en- hanced MR images: correlation with histopathologic findings. Radiology
  11. [CrossRef] Clement O, Muhler A, Vexler V, Berthezene Y, Brasch RC. Gadolini- um-ethoxybenzyl-DTPA, a new liv- er-specific magnetic resonance contrast agent. Kinetic and enhancement pat- terns in normal and cholestatic rats. In- vest Radiol 1992
  12. [CrossRef] Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T. Potential for differential diagnosis with gadolinium-ethoxyben- zyl-diethylenetriamin